AXA Framlington Biotech R Class Acc

Register to Unlock Ratings
Morningstar Rating™(Relative to Category)30/09/2021
 Morningstar ReturnMorningstar RiskMorningstar Rating™
3-YearAbove AverageAverage4 star
5-YearAbove AverageAverage4 star
10-YearAbove AverageAbove Average4 star
OverallAbove AverageAbove Average4 star
Click here to see our Methodology
1 Year Daily Volatility Chart (annualised)
  • AXA Framlington Biotech R Class Acc
  • NASDAQ Biotechnology TR USD
Volatility Measurements30/09/2021
3-Yr Std Dev21.88 %
3-Yr Mean Return11.31 %
3-Yr Sharpe Ratio0.47
Modern Portfolio Statistics30/09/202130/09/2021
 Standard IndexBest Fit Index
 NASDAQ Biotechnology TR USD  NASDAQ Biotechnology PR USD
3-Yr Beta0.940.94
3-Yr Alpha0.300.86
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(